Krystal Biotech Inc Earnings

Krystal Biotech Inc’s revenue jumped 17.52% since last year same period to $107.11Mn in the Q4 2025. On a quarterly growth basis, Krystal Biotech Inc has generated 9.51% jump in its revenue since last 3-months.

Krystal Biotech Inc’s net profit jumped 13.02% since last year same period to $51.4Mn in the Q4 2025. On a quarterly growth basis, Krystal Biotech Inc has generated -35.24% fall in its net profits since last 3-months.

Krystal Biotech Inc’s net profit margin fell -3.83% since last year same period to 47.99% in the Q4 2025. On a quarterly growth basis, Krystal Biotech Inc has generated -40.86% fall in its net profit margins since last 3-months.

Krystal Biotech Inc’s earning per share (EPS) estimates for the current quarter stand at 1.46 - a -7.59% fall from last quarter’s estimates.

Krystal Biotech Inc’s earning per share (EPS) estimates for the current year stand at 1.46.

Krystal Biotech Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Krystal Biotech Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.